- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Senores Pharmaceuticals Limited — Updates, 18-09-2025: General Updates
18-09-2025 | 03:58 pm
18-09-2025 | 03:58 pm
Senores Pharma invested USD 1,999,968 cash into its US wholly-owned subsidiary, Senores Pharmaceuticals Inc. (SPI), via a rights issue for SPI's working capital. This utilizes IPO funds. SPI, holding key intellectual property, reported USD 11,414,255 turnover in FY25.
No comments yet. Be the first to comment!